According to a survey conducted in 2024, almost three quarters of surveyed biopharma executives stated that it is extremely likely or very likely that their company will outsource patient recruitment within the next two years. This statistic describes the likelihood of outsourcing select drug development activities among biopharmaceutical companies, within the next two years.
Likelihood of outsourcing select drug development activities in the next 2 years among biopharmaceutical companies worldwide as of 2024
Respondents from large companies: n=64, from small/mid: n=86
Method of interview
Panel survey
Supplementary notes
The respondents are working for pharma, biopharma, or
biotech companies; they have drug development decision-making responsibility and
are director-level or above; they work in a role related to drug development; their companies have at least one compound in development; they are from the US/Canada, Europe, and Asia.
Original question: "Using the scale provided, please indicate how likely your company is to outsource each
of the below drug development activities in the next 2 years?"
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Thermo Fisher (PPD). (September 16, 2024). Likelihood of outsourcing select drug development activities in the next 2 years among biopharmaceutical companies worldwide as of 2024 [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1414301/outsourcing-drug-development-activities-by-companies/
Thermo Fisher (PPD). "Likelihood of outsourcing select drug development activities in the next 2 years among biopharmaceutical companies worldwide as of 2024." Chart. September 16, 2024. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1414301/outsourcing-drug-development-activities-by-companies/
Thermo Fisher (PPD). (2024). Likelihood of outsourcing select drug development activities in the next 2 years among biopharmaceutical companies worldwide as of 2024. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1414301/outsourcing-drug-development-activities-by-companies/
Thermo Fisher (PPD). "Likelihood of Outsourcing Select Drug Development Activities in The next 2 Years among Biopharmaceutical Companies Worldwide as of 2024." Statista, Statista Inc., 16 Sep 2024, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1414301/outsourcing-drug-development-activities-by-companies/
Thermo Fisher (PPD), Likelihood of outsourcing select drug development activities in the next 2 years among biopharmaceutical companies worldwide as of 2024 Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1414301/outsourcing-drug-development-activities-by-companies/ (last visited November 10, 2024)
Likelihood of outsourcing select drug development activities in the next 2 years among biopharmaceutical companies worldwide as of 2024 [Graph], Thermo Fisher (PPD), September 16, 2024. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1414301/outsourcing-drug-development-activities-by-companies/
